GlassScriptPhysician profile
Matthew Igbinigie
NPI 1700383486
$1,379.86
in general payments reported to CMS, 2019-2025
7 companies · $863 in 2025
The $863 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $517 · 2025: $863.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $379.68 | 2024-2025 | Excelsius Gps, Reline, Simplify Cervical Artificial Disc |
| Boston Scientific Corporation | $340.18 | 2024 | Infinion 16 |
| Neo Spine USA, INC. | $330.26 | 2025 | Neo Pedicle Screw System |
| Medtronic, INC. | $281.01 | 2024-2025 | Aquamantys(Tm), Unid_pass, Cd Horizon Spinal System |
| Ferring Pharmaceuticals INC. | $18.68 | 2024 | Euflexxa |
| Axogen | $16.04 | 2024 | Axoguard Nerve Cap, Axoguard Nerve Protector, Axoguard Ha+ Nerve Protector |
| Electronic Waveform Lab, INC. | $14.01 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Igbinigie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.